Suppr超能文献

比较有母源抗体猪的不同 CSF 疫苗的效力。

Comparative efficacy evaluation of different CSF vaccines in pigs with CSF maternally derived antibodies.

机构信息

Boehringer Ingelheim Vetmedica (China) Co. Ltd., Taizhou 225300, People's Republic of China.

World Organisation for Animal Health, Reference Laboratory for Classical Swine Fever, China Institute of Veterinary Drug Control, Beijing 100081, People's Republic of China.

出版信息

Vet Microbiol. 2022 Oct;273:109541. doi: 10.1016/j.vetmic.2022.109541. Epub 2022 Aug 8.

Abstract

Classical swine fever (CSF) is a highly contagious and important swine disease in China. Sporadic outbreaks with mild clinical signs are still being reported despite massive vaccination with the CSF C-strain vaccine. One possible reason for vaccine failure could be interference from maternally derived antibodies (MDAs) during vaccination in the field. The aim of this study was to evaluate the efficacy of different CSF vaccines in the presence of MDAs and to assess the different vaccination schemes in the field. The results demonstrated that vaccination with a single dose of C-strain-PK vaccine protected pigs against severe clinical signs and significantly reduced viremia. The impact of MDAs was negligible. The interference was also mild during a prime and boost vaccination scheme using the C-strain-ST vaccine. In contrast, a significant influence of MDAs on the efficacy of the subunit E2 vaccine in a one-dose vaccination scheme was observed, with pigs showing severe clinical signs, CSF-associated death, typical pathological lesions and a high level of viremia after challenge, despite robust E2 antibody induction. A field vaccination and challenge study further confirmed the superior effectiveness of a single dose of C-strain-PK vaccine in the presence of MDAs in comparison to a routine prime and boost vaccination scheme applied in the field, with pigs having fever, chronic signs, significant viremia and shedding after challenge. Delaying the vaccination time from the age of 28 days to 45 days, when MDA was low, was beneficial for improving the clinical protection and immunity induced by vaccines. Altogether, the results presented here emphasize that a high-quality vaccine and a scientific design of the vaccination scheme based on serological surveillance are essential pillars to control and eliminate CSF in China.

摘要

经典猪瘟(CSF)是中国一种高度传染性和重要的猪病。尽管大规模使用 CSF C 株疫苗进行接种,但仍有零星暴发且临床症状较轻。疫苗失败的一个可能原因是在田间接种时母源抗体(MDA)的干扰。本研究旨在评估 MDA 存在时不同 CSF 疫苗的效力,并评估田间不同的接种方案。结果表明,单次接种 C 株-PK 疫苗可保护猪免受严重临床症状的侵害,并显著降低病毒血症。MDA 的影响可以忽略不计。在使用 C 株-ST 疫苗进行初免-加强免疫方案时,干扰也较轻。相比之下,在单次接种方案中,E2 亚单位疫苗的效力受到 MDA 的显著影响,尽管产生了强烈的 E2 抗体,但接种后的猪出现严重的临床症状、CSF 相关死亡、典型的病理病变和高水平的病毒血症。田间接种和挑战研究进一步证实,与在田间应用的常规初免-加强免疫方案相比,在 MDA 存在的情况下,单次接种 C 株-PK 疫苗具有更高的有效性,接种后的猪出现发热、慢性症状、显著的病毒血症和排毒。将接种时间从 28 天推迟到 45 天,此时 MDA 水平较低,有利于提高疫苗诱导的临床保护和免疫力。总之,这里呈现的结果强调,高质量的疫苗和基于血清学监测的科学接种方案设计是在中国控制和消灭 CSF 的重要支柱。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验